Tandem Diabetes Care, Inc.
Reports in 10d· 2026-05-07
-1.6% · 90d
$19.82
-0.54 (-2.65%)
After-Hours $19.82(+0.00)
News
(1)April 2026
TNDM Shareholders Vote on Executive Pay After $1 Billion Sales
TNDMTANDEM DIABETES CARE INC
# 🧾 What This Document Is This is a **proxy statement** (DEF 14A), a formal document public companies must send to shareholders before an annual meeting. Think of it as the agenda and information packet for that meeting. 👉 **Why it matters:** It tells you what shareholders will vote on, who is on
Read summaryView on SEC EDGAR
Peers in Medical Devices
ABT#1
Abbott Laboratories
$178.90B-0.81%
SYK#2
Stryker Corporation
$129.79B-0.26%
MDT#3
Medtronic plc
$112.87B-0.83%
BSX#4
Boston Scientific Corporation
$91.07B-2.05%
EW#5
Edwards Lifesciences Corporation
$45.63B-3.13%
GEHC#6
GE HealthCare Technologies Inc.
$33.27B-1.14%
PHG#7
Koninklijke Philips N.V.
$26.70B+0.29%
DXCM#8
DexCom, Inc.
$25.28B-0.18%
STE#9
STERIS plc
$21.94B-0.57%
ZBH#10
Zimmer Biomet Holdings, Inc.
$18.01B+0.02%